Search

van Vollenhoven, R. F., B. H. Hahn, G. C. Tsokos, P. Lipsky, R. M. Gordon, K. Fei, K. H. Lo, et al. 2022. “Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study”. J Rheumatol 49: 380-87.

Tsokos, G. C. 2022. “Engineered T Cells to Treat Lupus Arrive on the Scene”. Nature 611: 456-58.

Satyam, A., R. Hisada, R. Bhargava, M. G. Tsokos, and G. C. Tsokos. 2022. “Intertwined Pathways of Complement Activation Command the Pathogenesis of Lupus Nephritis”. Transl Res 245: 18-29.

Chen, P. M., E. Katsuyama, A. Satyam, H. Li, J. Rubio, S. Jung, S. Andrzejewski, et al. 2022. “CD38 Reduces Mitochondrial Fitness and Cytotoxic T Cell Response Against Viral Infection in Lupus Patients by Suppressing Mitophagy”. Sci Adv 8: eabo4271.

Boulougoura, A., and G. C. Tsokos. 2022. “Ikaros, Aiolos and Other Moving Targets to Treat SLE”. Nat Rev Rheumatol 18: 499-500.

Umeda, M., N. Yoshida, R. Hisada, C. Burbano, S. Y. K. Orite, M. Kono, V. C. Kyttaris, S. Krishfield, C. A. Owen, and G. C. Tsokos. 2021. “ADAM9 Enhances Th17 Cell Differentiation and Autoimmunity by Activating TGF-Beta1”. Proc Natl Acad Sci U S A 118.

Li, P., M. Jiang, K. Li, H. Li, Y. Zhou, X. Xiao, Y. Xu, et al. 2021. “Glutathione Peroxidase 4-Regulated Neutrophil Ferroptosis Induces Systemic Autoimmunity”. Nat Immunol 22: 1107-17.

Li, H., and G. C. Tsokos. 2021. “IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases”. Clin Rev Allergy Immunol 60: 31-45.

Kolios, A. G. A., N. Yoshida, and G. C. Tsokos. 2021. “New Therapeutic Approaches in Systemic Lupus Erythematosus”. Curr Opin Rheumatol 33: 181-89.

Kolios, A. G. A., and G. C. Tsokos. 2021. “Skin-Kidney Crosstalk in SLE”. Nat Rev Rheumatol 17: 253-54.